Description

3-Quinolinecarboxylic Acid, 1-Cyclopropyl-6-Fluoro-1,4-Dihydro-4-Oxo-7-(1-Piperazinyl)- is a high-purity, advanced pharmaceutical intermediate belonging to the fluoroquinolone class of compounds. This compound is critical for the synthesis of next-generation antibacterial agents, offering a key structural moiety essential for potent biological activity. It is primarily required by pharmaceutical R&D laboratories and active pharmaceutical ingredient (API) manufacturers focused on developing novel anti-infective therapies.

Application

• Key Intermediate for Antibacterial Agents: Serves as a crucial building block in the synthesis of advanced fluoroquinolone antibiotics.
• Pharmaceutical Research & Development: Used in medicinal chemistry for the discovery and optimization of new antibacterial drug candidates.
• Active Pharmaceutical Ingredient (API) Manufacturing: Incorporated into the final chemical synthesis steps for producing bulk antibiotic APIs.
• Reference Standard: Employed as a high-purity analytical standard for quality control and regulatory testing in pharmaceutical production.
• Process Chemistry & Scale-Up: Utilized in developing and optimizing scalable, cost-effective manufacturing routes for complex drug molecules.

Basic Information

Product Name	3-Quinolinecarboxylic Acid, 1-Cyclopropyl-6-Fluoro-1,4-Dihydro-4-Oxo-7-(1-Piperazinyl)-
CAS No.	1234562-12-9
Molecular Formula	C17H18FN3O3
Molecular Weight	331.35 g/mol
Synonyms	1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(piperazin-1-yl)quinoline-3-carboxylic acid; 7-(1-Piperazinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid; Ciprofloxacin Intermediate; Fluoroquinolone Carboxylic Acid Intermediate; 1-Cyclopropyl-6-fluoro-7-(piperazin-1-yl)quinolin-4(1H)-one-3-carboxylic acid; CPFX Intermediate; Quinolone Derivative
EINECS	Contact for details

Quality Control

Our 3-Quinolinecarboxylic Acid derivative is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the stringent requirements for pharmaceutical intermediates. A comprehensive Certificate of Analysis (COA) detailing all specifications is provided with every shipment to guarantee traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated place at a controlled room temperature (15-25°C). This material is hygroscopic (moisture-sensitive) and light-sensitive; containers must be kept tightly sealed to prevent degradation from atmospheric moisture and light exposure.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.5%
Related Substances (HPLC)	Total impurities ≤ 1.5%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.